Metoclopramide is used for the symptomatic treatment of post-operative or chemotherapy-induced nausea and vomiting, gastroesophageal reflux disease and gastroparesis. Metoclopramide is generally ...

Metoclopramide is a central dopamine D2-receptor antagonist used as an antiemetic and gastroprokinetic agent in dogs and cats 1,2,3,4. It has been used experimentally in pigeons as an antiemetic ...

Get detailed information on Metoclopramide, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated ...

Diabetes mellitus is a risk factor for the development of gastroparesis. Currently, metoclopramide is the only US FDA-approved medication for the treatment of gastroparesis. However, the FDA ...

Metoclopramide stimulates motility of the upper gastrointestinal tract without stimulating gastric, biliary, or pancreatic secretions. The exact mechanism of action of metoclopramide in the ...

Metoclopramide (as HCl) 5mg; mint flavor. Allow tablet to dissolve on tongue. 10–15mg 4 times daily 30mins before meals and at bedtime. Intermittent symptoms: up to 20mg prior to provoking ...

Find all the commercial and brand names of generic drug called Metoclopramide. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...

Medically reviewed by Suzanne Fisher, RD If you’re one of the 85% of American adults who drink alcohol, whether occasionally ...

Evoke Pharma shares rose 70% on Monday after presenting data on Gimoti in GLP-1 users. Shares were trading around $9 in recent trading. The stock is down more than 28% on the year so far.

GIMOTI third quarter net product sales of $2.7 million, highest quarterly revenue ever with a 70% increase year-over-yearStrong cumulative ...

Evoke Pharma Inc. (EVOK) and Eversana Life Science Services, LLC. announced statistically significant comparative data on its study ...

Evoke Pharma reports positive results for a study on GIMOTI. Evoke Pharma stock has now tripled since early September.